進行再発胃癌に対するTS-1の2週投与1週休薬投与法（OGSG0103）

Phase II study of a combination of docetaxel and irinotecan in patients with advanced/recurrent gastric cancer. Osaka Gastrointestinal Cancer Chemotherapy Study Group OGSG